RSV immunization update

There is a shortage of the much-anticipated RSV immunization after approval just prior to RSV season

We have recently learned that we will receive very small supplies of the infant RSV immunization nirsemivab for the '23-'24 season, much to our disappointment. Our orders of this product have been cut or will be left unfilled. Pediatricians and families around the country are facing a shortage after initially being told that supplies would be adequate. In light of this, the CDC has issued guidelines for distributing limited product. We will only be able to vaccinate a small percentage of our patients who qualify and will focus on premature infants, infants with high-risk conditions such as cystic fibrosis, and the youngest babies while supplies last. We are keeping a list and contacting parents as additional doses arrive.

For pregnant people, we encourage you to receive the vaccine if offered by your obstetrician during the 23-24 RSV season. Infants whose mothers receive the dose during pregnancy do not need the dose in infancy. We have learned that many local obstetric offices will have this available.

We are very sorry that this season will be frustrating for new parents and are continuing to seek doses if they become available.